333 related articles for article (PubMed ID: 9225644)
1. The possible use of antiprogestins for contraception.
Bygdeman M; Danielsson KG; Swahn ML
Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
[TBL] [Abstract][Full Text] [Related]
2. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
3. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
4. Contraceptive use of antiprogestin.
Bygdeman M; Danielsson KG; Marions L; Swahn ML
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
[TBL] [Abstract][Full Text] [Related]
5. Antiprogestogens: from abortion to contraception.
Prog Hum Reprod Res; 1992; (22):6-7. PubMed ID: 12286013
[TBL] [Abstract][Full Text] [Related]
6. Antiprogestins: mechanism of action and contraceptive potential.
Spitz IM; Croxatto HB; Robbins A
Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
[TBL] [Abstract][Full Text] [Related]
7. The use of progesterone antagonists and progesterone receptor modulators in contraception.
Spitz IM; Van Look PF; Coelingh Bennink HJ
Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
[TBL] [Abstract][Full Text] [Related]
8. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
9. GnRH antagonists and antiprogestins: novel contraceptive options.
Gordon K; Heikinheimo O; Goodman AL
Adv Contracept Deliv Syst; 1994; 10(3-4):207-15. PubMed ID: 12287839
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term low-dose mifepristone on reproductive function in women.
Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
[TBL] [Abstract][Full Text] [Related]
12. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
13. The potential of mifepristone (RU486) as a female contraceptive drug.
Sarkar NN
Int J Clin Pract; 2002 Mar; 56(2):140-4. PubMed ID: 11926701
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-dose mifepristone administration in two different 14-day regimens on the menstrual cycle and endometrial development: a randomized controlled trial.
Chen Y; Wang W; Zhuang Y; Chen X; Huang L
Contraception; 2011 Jul; 84(1):64-70. PubMed ID: 21664512
[TBL] [Abstract][Full Text] [Related]
15. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Ghosh D; Nayak NR; Sengupta J
Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone: a potential contraceptive.
Heikinheimo O; Archer DF
Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
[TBL] [Abstract][Full Text] [Related]
17. [Study on weekly low doses of mifepristone for contraception].
Cheng J; Weng L; Han X
Zhonghua Fu Chan Ke Za Zhi; 2001 Jul; 36(7):424-7. PubMed ID: 11718031
[TBL] [Abstract][Full Text] [Related]
18. Hormonal requirement for blastocyst implantation and a new approach for anti-implantation strategy.
Ghosh D; Nayak NR; Kumar PG; Dhara S; Sengupta J
Indian J Physiol Pharmacol; 1997 Apr; 41(2):101-8. PubMed ID: 9142552
[TBL] [Abstract][Full Text] [Related]
19. Effects of mifepristone on endometrial receptivity.
Danielsson KG; Marions L; Bygdeman M
Steroids; 2003 Nov; 68(10-13):1069-75. PubMed ID: 14668000
[TBL] [Abstract][Full Text] [Related]
20. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
